Hill-Rom (NYSE:HRC) updated its first quarter earnings guidance on Tuesday. The company provided earnings per share guidance of $0.77-0.79 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.79. The company issued revenue guidance of $670 million, compared to the consensus revenue estimate of $656.42 million.
A number of analysts have recently weighed in on the company. Zacks Investment Research lowered Hill-Rom from a buy rating to a hold rating in a research report on Tuesday. Raymond James Financial raised Hill-Rom from a market perform rating to an outperform rating and set a $94.00 price objective on the stock in a research report on Wednesday, January 3rd. Morgan Stanley lowered Hill-Rom from an overweight rating to an equal weight rating in a research report on Tuesday, January 2nd. They noted that the move was a valuation call. KeyCorp reaffirmed a buy rating and set a $94.00 price objective on shares of Hill-Rom in a research report on Thursday, December 21st. Finally, ValuEngine lowered Hill-Rom from a buy rating to a hold rating in a report on Friday, December 1st. Six equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The stock currently has a consensus rating of Hold and a consensus price target of $91.75.
Hill-Rom (NYSE HRC) opened at $88.34 on Wednesday. The company has a market capitalization of $5,810.00, a price-to-earnings ratio of 44.39, a P/E/G ratio of 1.65 and a beta of 1.19. The company has a quick ratio of 1.34, a current ratio of 1.77 and a debt-to-equity ratio of 1.55. Hill-Rom has a twelve month low of $55.04 and a twelve month high of $88.91.
Hill-Rom (NYSE:HRC) last posted its earnings results on Friday, November 3rd. The medical technology company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.27 by $0.05. The firm had revenue of $738.30 million for the quarter, compared to analyst estimates of $731.10 million. Hill-Rom had a return on equity of 21.07% and a net margin of 9.36%. Hill-Rom’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.18 earnings per share. equities analysts expect that Hill-Rom will post 4.32 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, December 29th. Shareholders of record on Friday, December 15th were paid a $0.18 dividend. The ex-dividend date was Thursday, December 14th. This represents a $0.72 annualized dividend and a yield of 0.82%. Hill-Rom’s dividend payout ratio is presently 36.18%.
In other Hill-Rom news, SVP Paul Sherwood Johnson sold 1,000 shares of the company’s stock in a transaction on Wednesday, December 13th. The shares were sold at an average price of $82.99, for a total value of $82,990.00. Following the completion of the transaction, the senior vice president now owns 1,066 shares in the company, valued at $88,467.34. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO John J. Greisch sold 100,000 shares of the company’s stock in a transaction on Tuesday, December 12th. The shares were sold at an average price of $82.82, for a total transaction of $8,282,000.00. Following the completion of the transaction, the chief executive officer now owns 230,851 shares of the company’s stock, valued at approximately $19,119,079.82. The disclosure for this sale can be found here. Insiders sold 226,241 shares of company stock valued at $18,708,644 in the last 90 days. 2.20% of the stock is currently owned by insiders.
COPYRIGHT VIOLATION WARNING: This story was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2018/01/10/hill-rom-hrc-updates-q1-earnings-guidance.html.
Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.